{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:19:22Z","timestamp":1791389962109,"version":"4.3.3"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>To characterize the frequency and risk of serious infections in patients with myasthenia gravis (MG) relative to age\/sex\/area\u2010matched comparators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a population\u2010based cohort study in Ontario, Canada of patients with newly\u2010diagnosed MG and 1:4 age\/sex\/area\u2010matched general population comparators accrued from 1 April 2002 to 31 December 2015. The main outcome was a serious infection, defined by a primary diagnosis code on a hospitalization or emergency department record. We computed crude overall and sex\u2010specific rates of infection among patients with MG and comparators, and the frequency of specific types of infection. Adjusted hazard ratios and 95% confidence intervals were estimated using Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3823 patients with MG, 1275 (33.4%) experienced a serious infection compared with 2973\/15\u00a0292 (19.4%) of comparators over a mean follow\u2010up of over 5\u00a0years. Crude infection rates among patients with MG were twice those in comparators (72.5 vs. 35.0 per 1000 person\u2010years, respectively). The most common infection types were respiratory infections, particularly bacterial pneumonia. After adjustment for potential confounders, MG was associated with a 39% increased infection risk (adjusted hazard ratio, 1.39; 95% confidence intervals, 1.28\u20131.51).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with MG are at a significantly higher absolute and relative risk of serious infections compared with age\/sex\/area\u2010matched comparators. This needs to be considered when selecting MG treatments and when planning vaccination\/prophylaxis. Determining whether this risk is due to the use of immunosuppressive medications (vs. MG itself) is an important area for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ene.14153","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T02:41:08Z","timestamp":1580352068000},"page":"702-708","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Serious infections in patients with myasthenia gravis: population\u2010based cohort study"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-8787","authenticated-orcid":false,"given":"C. D.","family":"Kassardjian","sequence":"first","affiliation":[{"name":"Division of Neurology Department of Medicine St Michael's Hospital University of Toronto Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Widdifield","sequence":"additional","affiliation":[{"name":"Holland Bone &amp; Joint Research Program Sunnybrook Health Sciences Centre Sunnybrook Research Institute Toronto ON"},{"name":"Institute of Health Policy, Management &amp; Evaluation University of Toronto Toronto ON"},{"name":"ICES Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management &amp; Evaluation University of Toronto Toronto ON"},{"name":"ICES Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kopp","sequence":"additional","affiliation":[{"name":"ICES Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nagamuthu","sequence":"additional","affiliation":[{"name":"ICES Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5546-0221","authenticated-orcid":false,"given":"C.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Division of Neurology Department of Medicine Ellen and Martin Prosserman Centre for Neuromuscular Diseases University Health Network University of Toronto Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine North York General Hospital University Health Network Toronto ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Breiner","sequence":"additional","affiliation":[{"name":"Division of Neurology Department of Medicine The Ottawa Hospital and Ottawa Hospital Research Institute Ottawa ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329200"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26032"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13255"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21812"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb22940.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26382"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144741"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002025"},{"key":"e_1_2_8_12_1","unstructured":"Health care in Ontario | Ontario.ca[Internet].https:\/\/www.ontario.ca\/page\/health-care-ontario(accessed 02\/07\/2019)."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.10.009"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412550903140865"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/963098"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.3.512"},{"key":"e_1_2_8_17_1","first-page":"e18","article-title":"Accuracy of administrative databases in identifying patients with hypertension","volume":"1","author":"Tu K","year":"2007","journal-title":"Open Med"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410150316"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2017.13.4.325"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21440"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8751-9"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.131430"},{"key":"e_1_2_8_23_1","first-page":"348","article-title":"Prophylaxis for pneumocystis pneumonia (PCP) in non\u2010HIV infected patients","volume":"25","author":"Anevlavis S","year":"2012","journal-title":"Pneumon"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.4065\/71.1.5"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212588"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.04.016"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fene.14153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.14153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ene.14153","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.14153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T16:35:03Z","timestamp":1693845303000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.14153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/ene.14153"],"URL":"https:\/\/doi.org\/10.1111\/ene.14153","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"2019-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}